EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, FOLD: Amicus Therapeutics

12 Dec 25 15:59
LAST:

10.56

CHANGE:
 0.65		OPEN:
9.96		HIGH:
11.00		ASK:
13.15		VOLUME:
9.13M
CHG(%):
6.57		PREV:
9.90		LOW:
9.78		BID:
7.16		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
12 Dec 259.9211.009.7810.5512.05M
11 Dec 259.849.979.749.903.85M
10 Dec 259.789.919.739.854.21M
09 Dec 259.859.949.799.813.62M
08 Dec 2510.0310.039.739.853.29M
05 Dec 259.9610.059.799.903.68M
04 Dec 259.679.999.639.952.95M
03 Dec 259.789.859.669.782.92M
02 Dec 259.8710.029.569.734.53M
01 Dec 259.9210.059.779.806.29M

PROFILE

Name:Amicus Therapeutics
About:Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally. The company's commercial product and product candidates consist of Galafold, an orally administered monotherapy for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant; and Pombiliti + Opfolda, a novel two-component treatment program for adults living with late-onset Pompe disease. It has collaboration and license agreement with GlaxoSmithKline to develop and commercialize Galafold. Amicus Therapeutics, Inc. was incorporated in 2002 and is headquartered in Princeton, New Jersey.
Sector:Healthcare
Industry:Biotechnology
Address:47 Hulfish Street, Princeton, NJ, United States, 08542
Website:https://amicusrx.com
CUSIP:03152W109
CIK:0001178879
ISIN:US03152W1099
FIGI:BBG000PLF6N0
LEI:549300MRD1SMUTNBPQ53

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-49.22 
Forward P/E:56.44 
PEG Ratio:-0.82 
Price to Sales:4.87 
Price to Book:13.62 
Profit Margin:-0.07 
Operating Margin:-0.05 
Return on Assets:0.02 
Return on Equity:-0.23 
EPS Ratio:-0.12 
Revenue:571.16M 
EBITDA:38.58M 
Shares:308.24M 
Market Cap:3.255B 

TECHNICAL INDICATORS

MA5:9.995.7%
MA10:9.916.5%
MA20:9.807.7%
MA50:9.1116.0%
MA100:8.2927.4%
MA200:7.5839.4%
STO9:64.57
STO14:64.57
RSI14:76.19 
MTM14:0.66
ROC14:0.07 
ATR:0.39 
Week High:11.004.2%
Week Low:9.738.6%
Month High:11.004.2%
Month Low:9.2439.4%
Year High:11.004.2%
Year Low:5.5191.7%
Volatility:4.80